凯发一触即发

目录产品 » Anti-Abatacept Antibody (CT.E8), mAb, Mouse
Anti-Abatacept Antibody (CT.E8), MAb, Mouse

BLI (Biolayer interferometry) binding affinity measurements of Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) to Abatacept.
Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) captured on MFC (Anti-Mouse IgG Fc) Probes can bind Abatacept with a dissociation constant (KD) of 2.88E-09M.

Anti-Abatacept Antibody (CT.E8), MAb, Mouse

Standard curve and specificity analysis of the detection of Abatacept by A02262 (CT.F3) and A02263 (CT.E8).

Abatacept standard samples at 8 concentrations were spiked with 10 µg/mL of human IgG. The test result demonstrated that the high concentration of human IgG did not interfere with the detection of Abatacept.
In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) was coated at a concentration of 1 μg/ml, and Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml. The same conclusion was reached when Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was used as a coated antibody at a concentration of 1 μg/ml and Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml (data not shown) In this assay, a four-parameter logistic curve fitting program was used to create a standard curve with the R-Square is greater than 0.99. The typicaldynamic range of the assay is 156-10,000 ng/ml and its sensitivity of detecting Abatacept is up to 156 ng/ml.

Anti-Abatacept Antibody (CT.E8), MAb, Mouse

Standard curve and specificity analysis of the detection of Abatacept by A02263 (CT.E8) and anti-human IgG Fc antibody.

Abatacept standard samples at 8 concentrations were spiked with 2 µg/mL of human IgG. The test result demonstrated that the high concentration of human IgG did not interfere with the detection of Abatacept.
In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was coated at a concentration of 1 μg/ml, and Mouse Anti-Human IgG Fc Antibody (50B4A9)[HRP], mAb (GenScript, A01854) was used as a detection antibody at a dilution of 1:2000.
In this assay, a four-parameter logistic curve fitting program was used to create a standard curve with the R-Square is greater than 0.99. The typicaldynamic range of the assay is 4.69-300 ng/ml and its sensitivity of detecting Abatacept is up to 4.69 ng/ml.

Anti-Abatacept Antibody (CT.E8), MAb, Mouse

MRD analysis of the detection of Abatacept in biological matrix by A02262 (CT.F3) and A02263 (CT.E8).

The MRD is the minimum dilution necessary for the detection of Abatacept in biological matrix with least interference. Serum samples from cynomolgus monkey were serially diluted to determine the MRD of this assay, and the test result suggestedthat MRD was as 1:10.
In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) was coated at a concentration of 1 μg/ml, and Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml.
In this MRD analysis, the same conclusion was reached when Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was used as a coated antibody at a concentration of 1 μg/ml and Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml (data not shown).

Anti-Abatacept Antibody (CT.E8), MAb, Mouse

MRD analysis of the detection of Abatacept in biological matrix by A02263 (CT.E8) and anti-human IgG Fc antibody.

The MRD is the minimum dilution necessary for the detection of Abatacept in biological matrix with least interference. Serum samples from cynomolgus monkey were serially diluted to determine the MRD of this assay, and the test result suggestedthat MRD was as 1:10.
In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was coated at a concentration of 1 μg/ml, and Mouse Anti-Human IgG Fc Antibody (50B4A9)[HRP], mAb (GenScript, A01854) was used as a detection antibody at a dilution of 1:2000.

Anti-Abatacept Antibody (CT.E8), mAb, Mouse

This product is specific for Abatacept
A02263
￥990

联系凯发一触即发
Specificity This product is specific for Abatacept.
Host Species Mouse
Immunogen Abatacept
Conjugate Unconjugated

Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
Sandwich ELISA 0.5-2 μg/ml
ELISA 0.01-1 µg/ml

Form Lyophilized
Storage Buffer Lyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
Reconstitution Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
Storage Instructions The lyophilized product remains stable for up to 1 year at -20 °C from the date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
Purification Protein A affinity column
Isotype Mouse IgG1, κ
Clonality Monoclonal
Clone ID CT.E8
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

  • Anti-Abatacept Antibody (CT.E8), MAb, Mouse
    • Anti-Abatacept Antibody (CT.E8), MAb, Mouse

    BLI (Biolayer interferometry) binding affinity measurements of Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) to Abatacept.
    Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) captured on MFC (Anti-Mouse IgG Fc) Probes can bind Abatacept with a dissociation constant (KD) of 2.88E-09M.

  • Anti-Abatacept Antibody (CT.E8), MAb, Mouse
    • Anti-Abatacept Antibody (CT.E8), MAb, Mouse

    Standard curve and specificity analysis of the detection of Abatacept by A02262 (CT.F3) and A02263 (CT.E8).

    Abatacept standard samples at 8 concentrations were spiked with 10 µg/mL of human IgG. The test result demonstrated that the high concentration of human IgG did not interfere with the detection of Abatacept.
    In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) was coated at a concentration of 1 μg/ml, and Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml. The same conclusion was reached when Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was used as a coated antibody at a concentration of 1 μg/ml and Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml (data not shown) In this assay, a four-parameter logistic curve fitting program was used to create a standard curve with the R-Square is greater than 0.99. The typicaldynamic range of the assay is 156-10,000 ng/ml and its sensitivity of detecting Abatacept is up to 156 ng/ml.

  • Anti-Abatacept Antibody (CT.E8), MAb, Mouse
    • Anti-Abatacept Antibody (CT.E8), MAb, Mouse

    Standard curve and specificity analysis of the detection of Abatacept by A02263 (CT.E8) and anti-human IgG Fc antibody.

    Abatacept standard samples at 8 concentrations were spiked with 2 µg/mL of human IgG. The test result demonstrated that the high concentration of human IgG did not interfere with the detection of Abatacept.
    In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was coated at a concentration of 1 μg/ml, and Mouse Anti-Human IgG Fc Antibody (50B4A9)[HRP], mAb (GenScript, A01854) was used as a detection antibody at a dilution of 1:2000.
    In this assay, a four-parameter logistic curve fitting program was used to create a standard curve with the R-Square is greater than 0.99. The typicaldynamic range of the assay is 4.69-300 ng/ml and its sensitivity of detecting Abatacept is up to 4.69 ng/ml.

  • Anti-Abatacept Antibody (CT.E8), MAb, Mouse
    • Anti-Abatacept Antibody (CT.E8), MAb, Mouse

    MRD analysis of the detection of Abatacept in biological matrix by A02262 (CT.F3) and A02263 (CT.E8).

    The MRD is the minimum dilution necessary for the detection of Abatacept in biological matrix with least interference. Serum samples from cynomolgus monkey were serially diluted to determine the MRD of this assay, and the test result suggestedthat MRD was as 1:10.
    In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) was coated at a concentration of 1 μg/ml, and Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml.
    In this MRD analysis, the same conclusion was reached when Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was used as a coated antibody at a concentration of 1 μg/ml and Anti-Abatacept Antibody (CT.F3), mAb, Mouse (GenScript, A02262) conjugated with Biotin was used as a detection antibody at a concentration of 0.8 μg/ml (data not shown).

  • Anti-Abatacept Antibody (CT.E8), MAb, Mouse
    • Anti-Abatacept Antibody (CT.E8), MAb, Mouse

    MRD analysis of the detection of Abatacept in biological matrix by A02263 (CT.E8) and anti-human IgG Fc antibody.

    The MRD is the minimum dilution necessary for the detection of Abatacept in biological matrix with least interference. Serum samples from cynomolgus monkey were serially diluted to determine the MRD of this assay, and the test result suggestedthat MRD was as 1:10.
    In the ELISA assay shown in this chart, Anti-Abatacept Antibody (CT.E8), mAb, Mouse (GenScript, A02263) was coated at a concentration of 1 μg/ml, and Mouse Anti-Human IgG Fc Antibody (50B4A9)[HRP], mAb (GenScript, A01854) was used as a detection antibody at a dilution of 1:2000.


Target Background Abatacept, also known as Orencia, is a medication utilized for the treatment of autoimmune diseases like rheumatoid arthritis. By interfering with the immune activity of T cells, Abatacept helps in managing these conditions. It is a fusion protein that combines the extracellular domain of CTLA-4 with the Fc region of the immunoglobulin IgG1. Abatacept is a medication that is utilized as a second-line treatment for adults with moderate to severe rheumatoid arthritis (RA). For individuals whose RA is severe and rapidly progressing, it can be used as a first-line treatment. Furthermore, Abatacept is also prescribed for the treatment of psoriatic arthritis and juvenile idiopathic arthritis.
Synonyms Abatacept, Orencia, Anti-CTLA-4 antibody, CTLA4lg, BMS-188667, CTL A4-Ig B7 Inhibitor, RG2077

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


喜欢新升级的网站吗？

讨厌

不喜欢

一般

喜欢

非常喜欢

*